Skip to content

Randomized Evaluation of Ten Allergy Skin Prick Test Devices

Randomized Evaluation of Ten Allergy Skin Prick Test Devices

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03509766
Enrollment
24
Registered
2018-04-26
Start date
2014-01-31
Completion date
2015-09-30
Last updated
2018-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis, Asthma, Food Allergy, Skin Testing

Keywords

allergic, rhinitis, allergy, asthma, food allergy, skin testing, skin prick test

Brief summary

The goal of this study is to compare ten current and readily available FDA approved allergy skin prick devices to determine the most sensitive and specific product and methods used for the diagnosis of allergic disease. The primary outcome will be to determine the analytical sensitivity and specificity of all ten skin prick devices by measuring wheal and flare response to histamine and control diluent in 1mm increments. Secondary outcomes include comparison of skin prick technique, optimum histamine concentration, patient comfort, reproducibility, and the comparability of high-resolution digital images.

Interventions

DEVICEHistamine skin testing

skin testing using histamine

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Masking description

Neither the subject nor the technician are masked as to which device is being placed. However, the investigator who reads the skin prick test results is blinded as to which device is which.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 18-65 with or without allergic disease

Exclusion criteria

* severe concurrent illness * uncontrolled asthma * extensive eczema * urticaria * dermatographism * pregnancy * those taking antihistamines within the previous 10 days * topical steroids * immunomodulatory drugs * long term use of oral steroids

Design outcomes

Primary

MeasureTime frameDescription
Wheal Response15 minutesCompare Wheal response among devices using 1mm precision. SPT test will be read at 15 min time point. The maximum wheal diameter will be recorded for each of ten skin prick devices. 3mm (and 2mm above negative control) qualify as a positive test.
Sensitivity15 minutesSensitivity is calculated by dividing the true positive wheals divided by true positives plus false negatives and multiplying by 100. For example one false negative out of 24 tests equals a sensitivity of 95.8%.

Secondary

MeasureTime frameDescription
Skin Prick Techniques/Methodology Ratio15 minutesCompare 1mg/ml versus 6mg/ml histamine base for Duotip II twist method. Maximum wheal diameter is measured for each concentration.

Countries

United States

Participant flow

Participants by arm

ArmCount
Skin Testing
All subject both allergic and non-allergic will be tested. There is only one (1) arm. Histamine skin testing: skin testing using histamine
24
Total24

Baseline characteristics

CharacteristicSkin Testing
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
24 Participants
Sex/Gender, Customized
Female
18 Participants
Sex/Gender, Customized
Male
6 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 24
other
Total, other adverse events
0 / 24
serious
Total, serious adverse events
0 / 24

Outcome results

Primary

Sensitivity

Sensitivity is calculated by dividing the true positive wheals divided by true positives plus false negatives and multiplying by 100. For example one false negative out of 24 tests equals a sensitivity of 95.8%.

Time frame: 15 minutes

ArmMeasureValue (NUMBER)
Skin TestingSensitivity95.8 percentage of tests true positive
Primary

Wheal Response

Compare Wheal response among devices using 1mm precision. SPT test will be read at 15 min time point. The maximum wheal diameter will be recorded for each of ten skin prick devices. 3mm (and 2mm above negative control) qualify as a positive test.

Time frame: 15 minutes

ArmMeasureValue (MEAN)Dispersion
Skin TestingWheal Response6.8 mmStandard Deviation 0.4
Secondary

Skin Prick Techniques/Methodology Ratio

Compare 1mg/ml versus 6mg/ml histamine base for Duotip II twist method. Maximum wheal diameter is measured for each concentration.

Time frame: 15 minutes

Population: All 24 subjects received DuoTip II with both 1mg/ml and 6mg/ml histamine. This 24 vs 24 SPT in 24 total subjects.

ArmMeasureValue (MEAN)Dispersion
Skin TestingSkin Prick Techniques/Methodology Ratio1 ratioStandard Deviation 0.01

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026